These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 6179182)

  • 1. A comparison of pentosan polysulphate (SP54) and heparin. I: Mechanism of action on blood coagulation.
    Fischer AM; Barrowcliffe TW; Thomas DP
    Thromb Haemost; 1982 Apr; 47(2):104-8. PubMed ID: 6179182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of pentosan polysulphate and heparin. II: Effects of subcutaneous injection.
    Fischer AM; Merton RE; Marsh NA; Williams S; Gaffney PJ; Barrowcliffe TW; Thomas DP
    Thromb Haemost; 1982 Apr; 47(2):109-13. PubMed ID: 6179183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of a sulfated polysaccharide on antithrombin III.
    Czapek EE; Kwaan HC; Szczecinski M
    J Lab Clin Med; 1980 Jun; 95(6):783-90. PubMed ID: 6155418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Localization of the inhibitory site(s) of pentosan polysulphate in blood coagulation.
    Wagenvoord R; Hendrix H; Soria C; Hemker HC
    Thromb Haemost; 1988 Oct; 60(2):220-5. PubMed ID: 2464199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolism of sodium pentosan polysulphate in man measured by a new competitive binding assay for sulphated polysaccharides--comparison with effects upon anticoagulant activity, lipolysis and platelet alpha-granule proteins.
    MacGregor IR; Dawes J; Pepper DS; Prowse CV; Stocks J
    Thromb Haemost; 1985 Jun; 53(3):411-4. PubMed ID: 2413564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of a pentosan polysulphate upon thrombin and factor Xa inactivation by antithrombin III.
    Scully MF; Kakkar VV
    Biochem J; 1984 Sep; 222(3):571-8. PubMed ID: 6207810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison between the effect of pentosan polysulphate heparin and antithrombin III injections in antithrombin III deficient patients.
    Fischer AM; Dautzenberg MD; Aurousseau MH; Béguin S; Goudemand J; Hemker HC
    Thromb Res; 1985 Jan; 37(2):295-307. PubMed ID: 2579452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The inhibition of thrombin-dependent positive-feedback reactions is critical to the expression of the anticoagulant effect of heparin.
    Ofosu FA; Sie P; Modi GJ; Fernandez F; Buchanan MR; Blajchman MA; Boneu B; Hirsh J
    Biochem J; 1987 Apr; 243(2):579-88. PubMed ID: 2443128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular weight of heparin versus biologic activity. Some additional considerations.
    Losito R; Losito C
    Semin Thromb Hemost; 1985 Jan; 11(1):29-33. PubMed ID: 2579437
    [No Abstract]   [Full Text] [Related]  

  • 10. The importance of thrombin inhibition for the expression of the anticoagulant activities of heparin, dermatan sulphate, low molecular weight heparin and pentosan polysulphate.
    Ofosu FA; Blajchman MA; Modi GJ; Smith LM; Buchanan MR; Hirsh J
    Br J Haematol; 1985 Aug; 60(4):695-704. PubMed ID: 2411283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rationale behind the development of low molecular weight heparin derivatives.
    Hirsh J; Ofosu F; Buchanan M
    Semin Thromb Hemost; 1985 Jan; 11(1):13-6. PubMed ID: 2579436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The antiheparin effect of a heparinoid, pentosan polysulphate. Investigation of a mechanism.
    Scully MF; Kakkar VV
    Biochem J; 1984 Mar; 218(3):657-65. PubMed ID: 6202294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The inhibition of the anticoagulant activity of heparin by platelets, brain phospholipids, and tissue factor.
    Ofosu FA; Cerskus AL; Hirsh J; Smith LM; Modi GJ; Blajchman MA
    Br J Haematol; 1984 Jun; 57(2):229-38. PubMed ID: 6733045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms for inhibition of the generation of thrombin activity by sulfated polysaccharides.
    Ofosu FA; Modi GJ; Hirsh J; Buchanan MR; Blajchman MA
    Ann N Y Acad Sci; 1986; 485():41-55. PubMed ID: 2436525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of sulfated polysaccharides on inhibition of thrombus formation initiated by different stimuli.
    Van Ryn-McKenna J; Gray E; Weber E; Ofosu FA; Buchanan MR
    Thromb Haemost; 1989 Feb; 61(1):7-9. PubMed ID: 2473537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of heparin cofactor II as the principal plasma cofactor for the antithrombin activity of pentosan polysulphate (SP54).
    Scully MF; Kakkar VV
    Thromb Res; 1984 Oct; 36(2):187-94. PubMed ID: 6209821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms for the anticoagulant effect of heparin and related polysaccharides.
    Ofosu FA
    Nouv Rev Fr Hematol (1978); 1988; 30(3):155-60. PubMed ID: 2971155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence on the clotting mechanism of sodium pentosan polysulfate (SP54) in comparison to commercial beef lung sodium heparin.
    Vinazzer H; Haas S; Stemberger A
    Thromb Res; 1980 Oct; 20(1):57-68. PubMed ID: 6163222
    [No Abstract]   [Full Text] [Related]  

  • 19. Anticoagulant activities of pentosan polysulphate (Hémoclar) due to release of hepatic triglyceride lipase (HTGL).
    Barrowcliffe TW; Gray E; Merton RE; Dawes J; Jennings CA; Hubbard AR; Thomas DP
    Thromb Haemost; 1986 Oct; 56(2):202-6. PubMed ID: 2433786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reactivity of a hereditary abnormal antithrombin III fraction in the inhibition of thrombin and factor Xa.
    Tran TH; Bondeli C; Marbet GA; Duckert F
    Thromb Haemost; 1980 Oct; 44(2):92-5. PubMed ID: 7455997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.